Silver Trend Alerts: Update 4th May 2011

By Editorial Team -
  • Price closed below 20 Daily Simple/Exponential Moving Average
  • Realized Profit:  USD 43.00 - USD 30.3/oz = USD 12.7/oz (142%)
  • Duration:  3 months
  • Return On Investment:  168 % per annum
  • Leverage: 10 X
  • Return On Investment:  1680 % per annum
 Please refer to previous posts:
http://onedaymba.blogspot.com/2011/03/online-gold-and-silver-trend-alerts.html
http://onedaymba.blogspot.com/2011/02/online-gold-and-silver-trend-daily.html
http://onedaymba.blogspot.com/search?updated-min=2010-01-01T00%3A00%3A00-08%3A00&updated-max=2011-01-01T00%3A00%3A00-08%3A00&max-results=3

Please feel free to share your experience under 'post a comment' for the benefit of other readers. Thank you!

Related terms: Forex, Gold, Silver, trend, alerts, signals, trading, investment, gold price, spot gold, price of gold, gold spot, forex trading, forex charts, forex factory, forex market, CFD, trader

Comments

Post a Comment

Pages

Popular posts from this blog

Top 10 ETF Picks for August 2025: Best Funds to Buy Now for Growth, Safety, and Diversification

By -
Image
Here are the top 10 ETF picks for August 2025, along with insights on whether they are worth considering for investment right now. This list blends global equity leaders, sector specialists in defense and metals, and broad market trackers—balancing momentum with diversification and risk management. Current market conditions and upcoming events like the U.S. Federal Reserve’s September meeting make August a timely opportunity to reallocate or accumulate: 1. SPDR S&P 500 ETF Trust (SPY) or Vanguard S&P 500 ETF (VOO) Broad U.S. equity exposure; strong performers with SPY up 8.9% YTD and focused on the AI rally and potential post-rate-cut growth ( 1 ,  2 ). Would buy: Yes, for long-term core holding and growth. 2. iShares Core S&P 500 ETF (IVV) Similar to SPY/VOO, highly liquid, low expense ratio. Would buy: Yes, for passive U.S. equity exposure ( 2 ). 3. VanEck Gold Miners ETF (GDX) or  DAXglobal Gold Miners Gold/silver miners are up 34%–68% YTD, fueled b...
Read more

Top XRP ETFs to Watch in 2025: Dominating Holdings, Low Fees, and Performance Insights

By -
Image
As the cryptocurrency market matures in 2025, XRP ETFs have emerged as essential instruments for investors seeking regulated and accessible exposure to this dynamic digital asset. With a growing variety of futures-based and physically backed spot ETFs now available across major markets like the U.S., Canada, and Europe, understanding the nuances of these products—including their fee structures, holdings, and performance—is crucial for making informed investment decisions. This article highlights the top XRP ETFs to watch in 2025, providing deep insights into their dominating holdings, low fees, and recent market impact, all organized in a clear list format for easy navigation. Whether you are a long-term investor or an active trader, this guide will help you identify opportunities and risks in the evolving XRP ETF landscape. 1. Leading XRP ETFs in 2025 ProShares Ultra XRP ETF (UXRP) Type: 2x leveraged futures-based ETF listed in the U.S. Launched: July 18, 2025 Key Features...
Read more

Top August 2025 ETFs: In-Depth Performance Reviews

By -
Image
Here is an in-depth performance review of the top ETFs for August 2025, highlighting key trends, returns, and sector strengths to help investors understand current market dynamics and make informed decisions: 1. Gold Miners and Basic Materials ETFs Leading the Pack The best-performing ETFs so far in 2025 are heavily concentrated in gold miners and basic materials sectors. For example, the DAXglobal® Gold Miners ETF has delivered an exceptional 66.3% return this year, remaining the top performer in its category. The DAXglobal® Gold Miners index is tracked primarily by the L&G Gold Mining UCITS ETF, which is domiciled in Ireland and was launched on 15 September 2008. This ETF is listed on European exchanges including: XETRA (Germany) with the ticker symbol ETLX Stuttgart Stock Exchange (Germany) also listing the same ticker GDX  is the flagship US-listed gold miners ETF with large assets and active trading, holding major gold mining stocks like Newmont, Barrick Gold, and Fran...
Read more

Top 10 Credit Cards for Hospital Bills in Singapore 2025

By Editorial Team -
Image
If you are looking for the best credit cards for hospital bills in Singapore , you've come to the right place. Whether you're dealing with big doctors' bills right now or regularly spend on your health, you may be interested in a credit card that offers rewards for medical spend. Most credit cards actively exclude hospital spend from earning rewards. So, to make things easier, the experts from Value Champion have scoured the terms & conditions of 100+ cards in Singapore to find which actually do provide cash rebates or miles. Earning Rewards on Hospital Bills & Why We Selected these Cards Medical bills, whether for a doctor or a hospital visit, can be quite expensive and are sometimes difficult to pay off all at once. Facing such a large bill can certainly be daunting, but doing so also presents the opportunity to earn significant cashback or miles (the greater the spend, the greater the return). Additionally, some credit cards offer 0% interest instalment plans wh...
Read more

Estate Planning in Malaysia: Importance, Process, Will vs Trust, and Challenging a Will

By Editorial Team -
Image
Estate planning is the process of preparing for the management and distribution of one's assets and properties upon death or incapacity. In Malaysia, estate planning is crucial to avoid legal issues and disputes among family members and beneficiaries. In this article, we will discuss the importance of estate planning in Malaysia, the estate planning process, will vs trust in Malaysia, and how to challenge a will in Malaysia. Why is Estate Planning Important in Malaysia? Without proper estate planning, the distribution of a deceased's assets and properties will be governed by the Distribution Act 1958 or the Islamic Family Law (Federal Territories) Act 1984 (applicable to Muslims). These laws may not necessarily reflect the deceased's wishes or the family's needs, causing disputes and legal battles among the beneficiaries. Moreover, estate planning can help reduce the burden of taxes and administrative costs on the beneficiaries. Proper planning can minimize or eliminate...
Read more

Top 10 Cancer Drug Companies of 2025

By -
Image
Merck, Roche and Celgene (now part of Bristol-Myers Squibb) have remained prominent players, but the market dynamics have shifted significantly in recent years. Aug 1, 2025 Update:  @POTUS  sent letters to 17 drug manufacturers outlining steps they must take to bring down prescription drug prices. ( source ) This increased competition is fueled by the success of blockbuster drugs like Keytruda (Merck), Tagrisso (AstraZeneca), and Ibrance (Pfizer), as well as the rapid adoption of immunotherapies and targeted treatments ( Verified Market Reports ). Look at 2017. The trio of drugmakers together held a 45.8% share of the market, with longtime cancer leader Roche controlling 26.4% all on its own. In 2024, though, market intelligence firm EvaluatePharma expects to see much more parity. The top three’s share will shrink to 26.2%, with Roche’s dropping all the way down to 11.9%. And the No. 2 through No. 5 companies—BMS, Johnson & Johnson, Pfizer, AstraZeneca and Merck—will boas...
Read more

AI predicts Nvidia stock price on August 31, 2025

By -
Image
Nvidia’s (NASDAQ: NVDA) stock price has taken a hit, retreating from its recent high above $180. However, artificial intelligence (AI) tools are projecting that the equity will likely reclaim this level by the end of August 2025. Notably, Nvidia was among the stocks affected by Friday’s market rout , triggered by new U.S. trade tariffs and disappointing July jobs data. NVDA closed the last session down 2.3%, trading at $173. Year to date, Nvidia is still up over 25%. NVDA stock price prediction  To estimate where Nvidia stock might head by the end of August,  Finbold’s AI price prediction tool  leveraged machine learning models,  GPT-4o , Claude 3.5 Sonnet, and Grok 2 Vision, alongside a suite of technical indicators, including Moving average convergence/divergence ( MACD ), Relative Strenghth Index ( RSI ), stochastic oscillators, and 50-day moving averages (MA). According to the tool’s output, Nvidia’s share price could reach $183.17 by August 31, 2025, signaling ...
Read more

Top 10 Pharmaceutical Companies by Revenue in 2025 (August Edition)

By -
Image
Here are the top 10 pharmaceutical companies by revenue as of 2025, updated based on second quarter 2025 revenue data. AstraZeneca, Novartis and Vertex each posted 12% sales increases, offering more evidence of their upward trajectories in recent years. Credit:  fiercepharma.com Only one of the top 10 drugmakers, Eli Lilly, is expected to achieve a double-digit revenue increase by the end of 2025. Eli Lilly is projecting a robust growth of around 32% in 2025 compared to 2024, driven by strong sales of its diabetes and weight-loss drugs such as Mounjaro and Zepbound, with full-year revenue guidance between $58 billion and $61 billion ( 1 ,  2 ,  3 ). Aug 1, 2025 Update:  @POTUS sent letters to 17 drug manufacturers outlining steps they must take to bring down prescription drug prices. ( source ) In contrast, most of the other top 10 pharmaceutical companies are expected to see more moderate revenue growth, generally in the range of 6% to 9% by the end of 2025. This r...
Read more

Did Steve Jobs Refuse Treatment for Pancreatic Cancer?

By Editorial Team -
Image
It’s been more than 12 years since the passing of Steve Jobs. Legendary Apple Inc., Co-founder Steve Jobs passed away at only 56 years old after battling pancreatic neuroendocrine tumor, a rare form of pancreatic cancer. A growing list of people in the public spotlight have faced pancreatic cancer, including tech innovators, entrepreneurs and influencers. In addition, and connected to Jobs, Jef Raskin, developer of the Macintosh computer, passed away of pancreatic cancer in 2005. And, coincidentally, Dag Kittlaus, creator of Siri, which was acquired by Apple in 2010, was diagnosed with the same exact cancer that took the life of Jobs. Pancreatic neuroendocrine tumors (or PNETs) account for less than 10% of all pancreatic cancer tumors and tend to grow slower than exocrine tumors, the most common type of pancreas tumors. Jobs survived eight years before dying of the disease on Oct. 5, 2011. The five-year survival rate for pancreatic cancer is only 10%. Since PNETs are so uncommon, trea...
Read more

Best Bitcoin ETFs of 2025: Should You Buy Today?

By -
Image
As of 2025, the Bitcoin ETF landscape is dominated by a mix of spot Bitcoin ETFs offering direct exposure to the cryptocurrency and Bitcoin futures strategy ETFs that provide exposure through futures contracts. The top Bitcoin ETFs expected to dominate based on holdings and fees reflect a balance between large assets under management (AUM), competitive expense ratios, and investor preferences for spot versus futures exposure. What Is a Spot Bitcoin ETF? Spot Bitcoin ETFs, which first began trading on U.S. exchanges Jan. 11, 2024, are exchange-traded funds that track the price of Bitcoin by directly holding the cryptocurrency itself, unlike the futures-based Bitcoin ETFs that have traded on exchanges since 2021. When an investor buys shares of a spot Bitcoin ETF, they are buying a portion of the Bitcoin held by the fund. Thus, a spot Bitcoin fund works in a similar way as a physically backed gold ETF . How to Choose the Best Spot Bitcoin ETF  Choosing the...
Read more